SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012041
Filing Date
2020-10-29
Accepted
2020-10-29 16:18:53
Documents
94
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20200930x10q.htm   iXBRL 10-Q 2518965
2 EX-31.1 bpmc-20200930xex31d1.htm EX-31.1 11757
3 EX-31.2 bpmc-20200930xex31d2.htm EX-31.2 11835
4 EX-32.1 bpmc-20200930xex32d1.htm EX-32.1 10665
  Complete submission text file 0001558370-20-012041.txt   9452259

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpmc-20200930.xsd EX-101.SCH 67220
6 EX-101.CAL bpmc-20200930_cal.xml EX-101.CAL 70250
7 EX-101.DEF bpmc-20200930_def.xml EX-101.DEF 256942
8 EX-101.LAB bpmc-20200930_lab.xml EX-101.LAB 550671
9 EX-101.PRE bpmc-20200930_pre.xml EX-101.PRE 481028
10 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20200930x10q_htm.xml XML 1713801
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 201272911
SIC: 2834 Pharmaceutical Preparations